I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Gianotti, N
1249
results:
Search for persons
X
Format
Online (1249)
Mediatypes
Articles (Online) (121)
Bookchapter (Online) (1)
OpenAccess-fulltext (1126)
Video (Online) (1)
Sorted by: Relevance
Sorted by: Year
?
1
Switching from tenofovir disoproxil fumarate to tenofovir a..:
Vergori, A.
;
Gagliardini, R.
;
Gianotti, N.
...
International Journal of Antimicrobial Agents. 56 (2020) 6 - p. 106154 , 2020
Link:
https://doi.org/10.1016/..
?
2
Rilpivirine plus cobicistat-boosted darunavir as a two-drug..:
Castagna, A
;
Rizzi, M
;
Valenti, D
...
Journal of Antimicrobial Chemotherapy. 75 (2020) 5 - p. 1332-1337 , 2020
Link:
https://doi.org/10.1093/..
?
3
Cardiovascular adverse events during treatment with darunav..:
Antinori, Andrea
;
Rusconi, S
;
Gianotti, N.
...
Drug Design, Development and Therapy. 13 (2019) - p. 1667-1685 , 2019
Link:
https://doi.org/10.2147/..
?
4
Association between time spent with residual viremia after ..:
Lazzarin, A.
;
Galli, L.
;
Galizzi, N.
...
Journal of Virus Eradication. 3 (2017) - p. 29 , 2017
Link:
https://doi.org/10.1016/..
?
5
Adherence To Treatment, Healthcare Resource Use And Costs R..:
Perrone, V
;
Sangiorgi, D
;
Blini, V
...
Value in Health. 20 (2017) 9 - p. A790 , 2017
Link:
https://doi.org/10.1016/..
?
6
In vitro phenotypes to elvitegravir and dolutegravir in pri..:
Canducci, F.
;
Ceresola, E. R.
;
Saita, D.
...
Journal of Antimicrobial Chemotherapy. 68 (2013) 11 - p. 2525-2532 , 2013
Link:
https://doi.org/10.1093/..
?
7
Residual viraemia does not influence 1 year virological reb..:
Gianotti, N.
;
Galli, L.
;
Racca, S.
...
Journal of Antimicrobial Chemotherapy. 67 (2012) 10 - p. 2541-2542 , 2012
Link:
https://doi.org/10.1093/..
?
8
Impact of lamivudine monotherapy in failing patients with m..:
Castagna, A
;
Galli, L
;
Bigoloni, A
...
Journal of the International AIDS Society. 15 (2012) S4 - p. 1-2 , 2012
Link:
https://doi.org/10.7448/..
?
9
Number of daily pills, dosing schedule, self‐reported adher..:
Gianotti, N
;
Galli, L
;
Bocchiola, B
...
HIV Medicine. 14 (2012) 3 - p. 153-160 , 2012
Link:
https://doi.org/10.1111/..
?
10
Durability of lopinavir/r monotherapy in people with viral ..:
d'Arminio Monforte, A
;
Cozzi‐Lepri, A
;
Andreoni, M
...
Journal of the International AIDS Society. 15 (2012) S4 - p. 1-1 , 2012
Link:
https://doi.org/10.7448/..
?
11
Immune recovery and T cell subset analysis during effective..:
Cossarini, F.
;
Galli, A.
;
Galli, L.
...
Journal of Antimicrobial Chemotherapy. 67 (2012) 10 - p. 2474-2478 , 2012
Link:
https://doi.org/10.1093/..
?
12
Residual viraemia does not influence 1 year virological reb..:
Gianotti, N.
;
Galli, L.
;
Racca, S.
...
Journal of Antimicrobial Chemotherapy. 67 (2011) 1 - p. 213-217 , 2011
Link:
https://doi.org/10.1093/..
?
13
Adherence, quality of life and number of daily pills in a l..:
Gianotti, N
;
Galli, L
;
Bocchiola, B
...
Journal of the International AIDS Society. 13 (2010) S4 - p. , 2010
Link:
https://doi.org/10.1186/..
?
14
Detecting impaired glucose tolerance or type 2 diabetes mel..:
Gianotti, N
;
Visco, F
;
Galli, L
...
HIV Medicine. 12 (2010) 2 - p. 109-117 , 2010
Link:
https://doi.org/10.1111/..
?
15
Prevalence of type 2 diabetes mellitus and its predictive f..:
Galli, L
;
Salpietro, S
;
Pellicciotta, G
...
Journal of the International AIDS Society. 13 (2010) S4 - p. , 2010
Link:
https://doi.org/10.1186/..
1-15